Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
09/2007
09/11/2007US7268235 Reacting a 5-( beta -ketoalkyl)-3-substituted-1,2,4-oxadiazoles compound with hydrazine
09/11/2007US7268166 Substituted 4-phenyl amino butane; spinal chord injuries, neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics
09/11/2007US7268133 Cannabinoid receptor ligands and uses thereof
09/11/2007US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/11/2007CA2397262C Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
09/11/2007CA2318368C Novel tricyclic compound
09/07/2007WO2007101156A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives
09/07/2007WO2007100851A1 Therapeutic compounds
09/07/2007WO2007098967A2 Imidazole compounds having pharmaceutical activity towards the sigma receptor
09/07/2007WO2007098963A1 Sigma receptor inhibitors
09/07/2007WO2007098953A1 Pyrazole derivatives as sigma receptor inhibitors
09/07/2007WO2007098826A2 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
09/07/2007CA2644068A1 Therapeutic compounds
09/07/2007CA2642931A1 Cyclohexylamino, benzene, pyridine, and pyridazine derivatives
09/07/2007CA2642813A1 Inhibitors of histone deacetylase
09/07/2007CA2641144A1 Pyrazole derivatives as sigma receptor inhibitors
09/07/2007CA2640757A1 Imidazole compounds having pharmaceutical activity towards the sigma receptor
09/07/2007CA2640754A1 Pyrazole derivatives as sigma receptors antagonists
09/07/2007CA2640753A1 Sigma receptor inhibitors
09/07/2007CA2637530A1 Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
09/06/2007US20070207984 Cyclohexylamino Benzene, Pyridine, and Pyridazine Derivatives
09/06/2007US20070207978 Stimulate mammalian coronary vasodilatation; imaging the heart; antiinflammatory; adjunctive therapy with angioplasty; platelet aggregation inhibitor; inhibitor of platelet and neutrophil activation;
09/05/2007EP1829873A1 Pyrrazole derivatives as sigma receptors antagonists
09/05/2007EP1829867A1 Imidazole compounds having pharmaceutical activity towards the sigma receptor
09/05/2007EP1829866A1 Sigma receptor inhibitors
09/05/2007EP1829865A2 Chemical compounds
09/05/2007EP1829863A1 Arylalkanoic acid derivative
09/05/2007EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof
09/05/2007EP1828182A2 Therapeutic pyrazolo[3,4-b]pyridines and indazoles
09/05/2007EP1828164A1 Method for preparing n-phenylpyrazole-1-carboxamides
09/05/2007EP1828140A1 5-aminopyrazole derivatives as pesticidal compounds
09/05/2007EP1828118A1 Parp inhibitors
09/05/2007EP1827446A2 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
09/05/2007EP1730116B1 4-carbox pyrazole derivates useful as anti-viral agents
09/05/2007EP1406892B1 Phenyl pyrazole derivatives as soluble epoxide hydrolase inhibitors
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN100335461C Arylsulfonanilide ureas
09/04/2007US7265246 7-Aminoakyl-2-arylcarbonylaminoindanes, e.g., 3-Fluorobiphenyl-4-carboxylic acid (R)-(6-((3-ethoxypropylamino)methyl)-2R-hydroxyindan-1-yl)amide; treatment of cognitive impairment associated with schizophrenia, Alzheimer's disease, and psychoses
09/04/2007US7265224 Red luminescent compound and organic electroluminescent device using the same
09/04/2007US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative
09/04/2007US7265149 Pyrazolylakoxy-substituted indoleacetic acid derivatives, e.g., {6-[2-methyl-5-(4-trifluoromethyl-phenyl)-2H-pyrazol-3-ylmethoxy]-indol-1-yl}-acetic acid; used for treatment and/or prevention of diseases modulated by PPAR delta and/or PPAR alpha agonists.
09/04/2007US7265144 Mixture with other active materials; controlling glucose metabolism
09/04/2007US7265130 anti-obestic activity; Neuropeptide Y antagonist
09/04/2007US7265112 Small molecule modulators of hepatocyte growth factor (scatter factor) activity
09/04/2007CA2413761C A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence
08/2007
08/30/2007WO2007097403A1 Remedy or preventive for digestive ulcer
08/30/2007WO2007096647A2 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
08/30/2007WO2007096058A1 Cycloalkylphenyl substituted cyclic ketoenols
08/30/2007US20070203342 Halogenation and oxidation of a 5-carboxyl-3-oxo-1-aryl-substituted-1H-pyrazolidine
08/30/2007US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol
08/30/2007US20070203201 Substituted anthranilamides for controlling invertebrate pests
08/30/2007US20070203197 Phosphodiesterase 4 inhibitors
08/30/2007US20070203196 Methods of preparing indazole compounds
08/30/2007US20070203148 Haloalkyl Carboxamides
08/30/2007US20070203101 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
08/30/2007US20070202160 Solid-state form of celecoxib having enhanced bioavailability
08/30/2007CA2643670A1 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer
08/30/2007CA2643272A1 Gent for treating or preventing digestive ulcer
08/30/2007CA2642787A1 Cycloalkylphenyl substituted cyclic ketoenols
08/29/2007EP1824845A1 1-arylpyrazoles and their use as pesticides
08/29/2007EP1824836A2 2-alkyl-cycloalk(en)yl-carboxamides
08/29/2007EP1824338A1 3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazols and the use of the same as herbicides
08/29/2007EP1590344A4 Anti-cancer medicaments
08/29/2007EP1578729A4 1-alkyl-3-aminoindazoles
08/29/2007EP1464642B1 Novel substituted pyrazole derivative, process for producing the same, and herbicidal composition containing the same
08/29/2007CN101027286A Indozolone derivatives as 11b-HSD1 inhibitors
08/29/2007CN101027285A Process for preparing bicyclic pyrazolyl compounds
08/29/2007CN101027053A Inhibitors of HSP90
08/28/2007US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds
08/28/2007US7262203 For therapy of hyperproliferative diseases such as cancer or retinopathy; pazopanib and salts
08/23/2007WO2007095513A1 Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators
08/23/2007WO2007094225A1 Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound
08/23/2007WO2007093829A1 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases
08/23/2007US20070197624 such as N-{5-[1-(4-chloro-phenyl)-1-methyl-ethyl]-2H-pyrazol-3-yl}-2-[2-(3,5-difluoro-phenyl)-2-hydroxy-acetylamino]-propionamide, used for inhibiting beta-amyloid peptide release and/or biosynthesis, inhibiting gamma-secretase activity, prevention and treatment of Alzheimer's disease
08/23/2007US20070197623 increases the effect on Sodium-dependent glucose cotransporters (SGLT); for lowering blood glucose; treatment of type 1 and type 2 diabetes; N-(2-Carbamoylethyl)-4-[1-(2-cyano-ethyl)-5-hydroxy-3-isopropyl-1H-pyrazol-4-ylmethyl]benzamide
08/23/2007US20070197522 Dpp-iv inhibitors
08/23/2007US20070196406 1,3-Dimethylbutyl carboxanilides for controlling undesirable micro-organisms
08/23/2007CA2642308A1 Process for production of 5-alkoxy-4-hydroxymethylpyrazole compound
08/22/2007EP1820503A2 Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
08/22/2007EP1819721A1 Microcin b17 analogs and methods for their preparation and use
08/22/2007EP1819692A1 3-ethylidenehydrazino substituted heterocyclic compounds as thrombopoietin receptor activators
08/22/2007EP1819691A2 Biaryloxymethylarene carboxylic acids
08/22/2007EP1819681A1 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
08/22/2007EP1819338A2 Tubulin binding anti cancer agents and prodrugs thereof
08/22/2007EP1379513B1 Prodrugs of cox-2 inhibitors
08/22/2007CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
08/22/2007CN101023069A 苯甲酰基取代的丝氨酸酰胺 Benzoyl substituted serine amide
08/22/2007CN101023062A Alpha,beta-unsaturated esters and acids by stereoselective dehydration
08/22/2007CN101020662A Compound 3,4-diaryl pyrazole and its prepn and medicinal use
08/21/2007US7259250 C-nitroso compounds and use thereof
08/21/2007US7259183 Indole, indazole and indoline derivatives as CETP inhibitors
08/16/2007WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
08/16/2007WO2007091396A1 Novel amidopropionic acid derivative and pharmaceutical product containing same
08/16/2007WO2007090949A1 Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same
08/16/2007WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives
08/16/2007WO2007090748A1 Benzamide and heteroarene derivatives
08/16/2007US20070191614 Process for producing nitrogenous 5-membered cyclic compound
08/16/2007US20070191613 Process for production of pyrazole-fused ring derivatives
08/16/2007US20070191358 Novel piperidine derivative for the treatment of depression
08/16/2007US20070190523 Method and compositions for identifying anti-hiv therapeutic compounds